By Julie Stauffer ([email protected])

Staying on top of new developments can be a daunting task in today’s hyper-connected world. If you’re feeling swamped in a sea of information, make the most of your reading time by zeroing in on these top picks.

To compile this list, we’ve drawn on different rankings from researchers around the world and thrown in a few personal choices for good measure. We’ve concentrated on publications that specialise in pharmacoeconomics and outcomes research, together with a few key health policy journals.

Where it exists, we’ve included the journal’s impact factor – a measure of how frequently its articles are cited in other publications.

The European Journal of Health Economics (previously HEPAC Health Economics in Prevention and Care): A good choice for insight into health care systems in Europe , offering a practical focus as well as academic rigour. Members of the International Health Economics Association receive a special rate.

Expert Review of Pharmacoeconomics and Outcomes Research : A peer-reviewed journal that offers commentary and analysis from leading experts, served up in an easily digested format. It covers the complete spectrum of outcomes research, including cost-benefit and pharmacoeconomic issues.

Health Affairs : Cited by the Washington Post as “the bible of health policy”. Boasting an impact factor of 3.369, this peer-reviewed, non-partisan journal of health policy and research covers US and international issues.

Health Economics : A must-read, with an impact factor of 2.030. Health Economics covers economic theory, empirical studies and analyses of health policy from an economic perspective. Members of the International Health Economics Association receive a special rate.

Journal of Health Economics : Another must-read with a similar impact factor. You’ll find peer-reviewed articles on the production of health and health services, demand and utilisation of health services, etc. Members of the International Health Economics Association receive a special rate.

The Milbank Quarterly : A venerable publication with a consistently high impact factor – most recently, 6.794. This multidisciplinary journal of population health and health policy offers a mix of peer-reviewed original research, policy review, in-depth analysis and commentary from academics, clinicians and policy makers.

PharmacoEconomics : A benchmark journal with an impact factor of 2.242 that offers practical, authoritative articles on applying pharmacoeconomics and quality-of-life assessment to drug therapy and health outcomes.

PharmacoEconomics and Outcomes News : Looking for a distillation of the latest research news? These bi-weekly summaries are selected by expert scientific editors from 1,400 biomedical publications and 50+ scientific meetings. You’ll find coverage of the economic impact of drugs and diseases, quality of life research, prescribing trends, regulatory news, etc – all in an easy-to-read format.

Quality of Life Research : A multidisciplinary publication with an impact factor of 2.037. This rapid-communication journal offers original research on topics spanning biometry, philosophy, social science, clinical medicine, health services and outcomes research.

Value in Health : The official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). This multidisciplinary publication with an impact factor of 3.433 offers an outlet for discussion and debate about the principles and substance of pharmacoeconomics and outcomes research.